机译:年龄不是多发性骨髓瘤患者自体外周血造血干细胞动员和收集的重要因素
Ankara University School of Medicine Department of Hematology;
Hematology Yildirim Beyazit University Yenimahalle Education and Research Hospital;
Ankara University School of Medicine Department of Hematology;
Ankara University School of Medicine Department of Hematology;
Ankara University School of Medicine Department of Hematology;
Department of Hematology and Stem Cell Transplantation Unit Ankara University Faculty of Medicine;
Department of Hematology and Stem Cell Transplantation Unit Ankara University Faculty of Medicine;
Hematology Ankara University School of Medicine;
Department of Hematology and Stem Cell Transplantation Unit Ankara University Faculty of Medicine;
Department of Hematology and Stem Cell Transplantation Unit Ankara University Faculty of Medicine;
Hematology Ankara University School of Medicine;
Department of Hematology and Stem Cell Transplantation Unit Ankara University Faculty of Medicine;
机译:年龄不是多发性骨髓瘤患者自体外周血造血干细胞动员和收集的重要因素
机译:普利克递对多发性骨髓瘤患者自体移植动员/收集外周造血干细胞的疗效和安全性
机译:评估接受自体造血外周血干细胞移植的淋巴瘤和多发性骨髓瘤患者与造血干细胞动员和转移相关的费用。
机译:具有自体造血干细胞移植(HSCT)的高剂量治疗用于初级全身淀粉样蛋白症(AL)的患者:ABMTR研究
机译:β-肾上腺素能受体介导的造血干细胞和祖细胞中的转录失调导致多发性骨髓瘤患者的骨髓红细胞抑制 - 以外的研究
机译:造血干细胞动员用于先前接触过环磷酰胺沙利度胺和地塞米松的多发性骨髓瘤患者的自体移植:单独使用粒细胞集落刺激因子是否足够?
机译:年龄不是多发性骨髓瘤患者自体外周血造血干细胞动员和收集的重要因素